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ABSTRACT
Salmonella Typhimurium, a major gastrointestinal pathogen, poses a global threat to human health. Public 
health problems associated with this organism have increased to the extent that it has become a major issue. The 
bacterium is becoming resistant to the commonly available antibiotics, and vaccines also suffer from limitations 
such as short lived immunity. Therefore, there is an urgent need for the development of an effective vaccine. 
The outer membrane proteins (Omps) of Salmonella have proven their capability to be developed as a vaccine 
candidate for prevention of salmonellosis. With this aim, in the present study the Omp28 gene of Salmonella 
Typhimurium was amplified, cloned and expressed under an IPTG induction system. The recombinant protein 
thus produced was purified and tested for its antigenicity. The antigenicity of the purified protein was confirmed 
by western blotting with antiserum raised in rabbit against Omps of S. Typhimurium. The Omp28 gene was 
amplified as a 330bp product. The expressed protein was found to be of approximately 28kDa and it produced 
a strong signal in western blot analysis. This study concluded that Omp28 may be proven to be an effective 
candidate for the development of r-DNA vaccine against salmonellosis. 
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Introduction 
Salmonella is the most important gastrointestinal pathogen distributed ubiquitously. 
It has a broad host range and zoonotic value. Salmonellosis has often been shown to be 
endemic for decades in humans (JOHN, 1996), animals (VERMA et al., 2001) especially 
in poultry products (FAVIER et al., 2013; LOPEZ et al., 2012). MURUNGKAR et al. 
(2005), reported an prevalence rate of 14.40% of S. enterica in the north eastern region 
of India. The incidence of Salmonella in chicken meat has been reported to range from 
6.79% to 97.6% using different methods (RAMYA et al., 2012). Of the total laboratory-
confirmed human Salmonella infections, Typhimurium was found to have an incidence 
rate of 1.85% (CDC, 2016).
Salmonella is facultative intracellular pathogen, able to survive both extracellularly 
and intracellularly. Further, the rising incidence of multiple drug resistance complicate 
its prevention and elimination strategies. S. Typhimurium, being an important serovar 
contributing to non-typhoidal salmonellosis (LAN et al., 2016), is of major concern. It 
causes various illnesses, from self-limiting gastroenteritis to life threatening systemic 
diseases (HARAGA et al., 2008). Vaccination is an important strategy to eliminate the 
condition, but the available vaccines suffer from limitations, such as short-term immunity 
and virulence restoration. The outer membrane proteins (Omps) from Salmonella have 
been proven to have good immunogenicity (LEE et al., 2010; GIL-CRUZ et al., 2009). 
Since that discovery, Salmonella Omps have been characterized (HAMID and JAIN, 
2008) and targeted for protection (JHA et al., 2015; SAXENA et al., 2012; BHAT and 
JAIN, 2010). Omp28 was isolated independently from S. Typhi by BHATNAGAR et 
al. (1982) and DE ANDRADE et al. (1998). Its complete amino acid sequence and 
location was deduced by NEVES-FERREIRA et al. (2004). In our previous study based 
on bioinformatic analysis, we proved that Omp28 of S. Typhimurium elicits both B and T 
cell mediated immunity, and has a high antigenic index (PANDEY and SAXENA, 2015). 
Therefore, it seemed to contain a promising vaccine candidate for poultry salmonellosis. 
Hence, in the present study we aimed to clone the gene, express the protein and explore 
its antigenicity, to prove Omp28 from S. Typhimurium to be an effective candidate to 
develop r-DNA vaccine for control of salmonellosis. 
Materials and methods
Bacterial strains and growth condition. The bacterial strains used in this study were 
Salmonella enterica, subspecies enterica, serovar Typhimurium, strain MTCC3231 
(IMTECH Chandigarh, India), Escherichia coli DH5α and M15 cells (Bangalore Genei, 
India). These cultures were stored at 4 °C in Luria Bertini (LB) agar slants and their 
glycerol stocks were also maintained at -20 °C. For the study, cultures were grown 
overnight at 37 °C in LB broth in an incubator cum shaker at 200 rpm. When required, 
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the above media were supplemented with ampicillin (100 μg/mL) and kanamycin (50 μg/
mL) antibiotics [Himedia, India]. Antiserum against Omps of S. Typhimurium raised in 
rabbit was procured from Animal Biotechnology Centre, GBPUA&T, Pantnagar (JHA et 
al., 2015). 
Cloning of the Salmonella Typhimurium Omp28 gene. Genomic DNA of Salmonella 
Typhimurium was isolated by the C-TAB method (WILSON, 1987). Using the 
available sequence information (GQ907044.1) from NCBI and GENETOOL software, 
oligonucleotide primers 5ʹGGATCCATGAATAAATTCTCCCTTGC3ʹ (forward) and 
5ʹAAGCTTTTATTTTGAGAGTTCTTTCTTGA3ʹ (reverse) were synthesized for 
amplification of the Omp28 gene. 25 μL PCR reaction mixture, containing 40 ng of 
genomic DNA, 20 pmole of primers, 200 μM of each dNTPs, 1.5 mM MgCl2 and 2 U of 
jumpstart polymerase (Sigma, USA). PCR was conducted in standard conditions with 
the following program: initial denaturation at 96 °C for 30 sec, followed by 30 cycles of 
denaturation at 94 °C for 15 sec, annealing at 46 °C for 30 sec, and elongation at 68 °C for 
30 sec, and a final extension at 68 °C for 5 mins. The size of the amplicon was measured 
by comparing it with a standard marker and it was eluted using an E.Z.N.A Gel extraction 
kit (Omega Bio-tek Inc.), followed by blunt end cloning in a Clone pJETTM PCR cloning 
kit (Fermentas, USA) in E. coli DH5α cells. The recombinant clones were grown in LB 
broth, and plasmids were isolated from them by the alkali lysis method (SAMBROOK 
and RUSSEL, 2001), which were then confirmed by insert release after double digestion, 
using NcoI and XhoI (Fermentas, USA) endonucleases.
Subcloning and expression of the Omp28 protein. pQE-30 expression vector was 
used for the directional subcloning of the Omp28 gene with a 6X His tag. Using BamHI 
and HindIII (Fermentas, USA) restriction endonucleases, the gene was released from the 
pJET 1.2/blunt cloning vector. The same restriction enzymes were also used to cut the 
pQE-30 expression vector. The digested insert and vector were ligated at 4 °C overnight, 
using T4 DNA ligase (Fermentas, USA), followed by transformation into competent 
E. coli M15 cells. Recombinants were selected on LB agar plate containing ampicillin 
(100 µg/mL) and kanamycin (50 µg/mL). Clones were inoculated into 3 mL of LB broth 
containing ampicillin (100 µg/mL) and kanamycin (50 µg/mL), and incubated at 37 °C 
in an incubator cum shaker at 200 rpm. The cultures were grown until they reached an 
OD600 of 0.6-0.8, that is approx. 4 hrs duration, after which cultures were induced with 
iso-1-propyl-thio-2-D-galactopyranoside i.e. IPTG to a final concentration of 1mM, and 
further incubated at 37 °C for 18 hrs. Expression was checked on 12.5% SDS (Sodium 
dodecyl sulphate) gel comparing it with the control (uninduced cells) (SAMBROOK and 
RUSSEL, 2001). The size of the recombinant protein was measured by comparing it with 
the protein molecular weight marker. Quantification of the expressed protein was done 
using Lowry’s method (LOWRY et al., 1951).
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Purification of recombinant protein. Purification of the recombinant protein was 
performed by the gel excision method (HAMID and JAIN, 2008). The desired protein 
band was removed from the gel with a scalpel blade, keeping the gel slice size to a 
minimum. Then the gel slice was put into a microcentrifuge tube, washed twice with 
triple glass distilled water, and then soaked in 1 mM DTT (Di-ThioThreitol) for 15 mins. 
Homogenization of the gel slice was carried out in a pestle and mortar. The required 
volumes of elution buffer (50 µL of 1 M DTT, 0.5 mL of 1.0 M Tris, 0.1 mL of 10% 
SDS, 0.3 mL of 5 M NaCl, 20 µL of 0.5 M EDTA) were added to make the final volume 
up to 10 mL by adding triple glass distilled water. This homogenized material was then 
incubated in elution buffer at 37 °C for 12 hrs in an incubator-cum-shaker, followed by a 
brief spin to remove the gel debris. The supernatant was removed and kept at -20 ºC until 
further use. 
Western blotting. The purified protein, along with the marker, was run on 12.5% 
SDS-PAGE using a discontinuous buffer system and subsequently transferred to a 
polyvinylidene difluoride (PVDF) membrane (Millipore, Germany) by the semi dry 
electroblotting method (TOWBIN et al., 1979). The transfer was carried out using a 0.8 
V/cm2 current applied for 1 hr. After that the PVDF membrane was immediately placed 
in blocking solution (3% BSA in PBS) and left overnight at 4 °C to block non-specific 
binding sites. The membrane was then washed with phosphate buffered saline (PBS) 
supplemented with 0.05% Tween-20 (PBST) [pH = 7.4] four times for 5 mins each, and the 
membrane was incubated with antisera raised in rabbit against Omps of S. Typhimurium 
at 1:50 dilution at 37 °C for 1 hr. After washing 4 times with PBST, the blot was again 
incubated at 37 °C for 1 hr with anti-rabbit horseradish peroxidase conjugated antibodies, 
at a dilution of 1:2000 in blocking buffer. The blot was washed with PBST four times for 
5 mins and transferred to freshly prepared 50 mL substrate solution (Ortho Phenylene 
Diamine as substrate and 6 µL of H2O2 (30%)). The colour was allowed to develop for 
a few minutes and then the reaction was stopped by rinsing the blot with distilled water. 
The blot was dried on filter paper and stored. 
Results and discussion
Salmonella Typhimurium causes one of the most common food-borne illnesses, 
which has been found to persist at the same rate for more than 15 years (NEWELL et al., 
2010). Being highly transferable between animal and human host systems, it has been a 
challenging task to control the spread and transmission of the infection. Multiple drug 
resistance is making the situation grimmer. So, there is an emergent need for a better 
vaccine. The Omps of Salmonella have been reported to be antigenically important and 
have exhibited promising potential as vaccine candidates (HAMID and JAIN, 2008). One 
such Omp from S. Typhimurium, i.e. Omp28, was evaluated in the current study. Upon 
amplification the size of the Omp28 gene from S. Typhimurium was found to be 330bp 
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(Fig. 1), which was similar to that observed by SAXENA et al. (2012) for the Omp28 
gene of S. Typhi. The amplified product was then cloned in pJET1.2/blunt end cloning 
vector and transformed in to DH5α cells. Positive clones were confirmed by colony PCR 
and the insert of the same size was also released by double digestion. 
Fig. 1. PCR amplicon of Omp28 gene of Salmonella Typhimurium. LaneM: Step UpTM 100bp 
DNA Marker (GeneiTM) Lane 1: PCR amplicon of Omp28 gene
The gene was subcloned in pQE-30 expression vector and on induction with IPTG 
(final conc. 1 mM) the recombinant protein was expressed at 28kD. The protein was 
purified by the gel excision method (Fig. 2.1) and recovery of protein was found to be 
approximately 10 mg/L of induced culture. The purified protein was transferred onto a 
PVDF membrane and on western blotting, with antiserum raised against Omp(s) of S. 
Typhimurium, a very strong signal was produced (Fig. 2.2), which further confirmed the 
antigenicity of the Omp28 protein. Earlier some researchers reported the formation of 
inclusion bodies in Omps expression (MANAT et al., 2016; YOUSEFI et al., 2016), but 
in our study we did not observe any inclusion body formation, even at a higher inducer 
concentration (IPTG). Omp28 protein is formed by three identical subunits which are not 
linked by disulfide bonds, representing a molecular mass of 28 kDa (NEVES-FERREIRA 
et al., 2004). Similarly, in this study upon induction by 1 mM IPTG conc. the protein 
was expressed at 28 kDa in trimeric form, which probably masked the histidine tag of 
the protein and we were unable to purify the protein by affinity chromatography. So the 
protein was purified by the gel excision method. The identity of this 28 kDa protein 
was confirmed by western blotting, using antisera raised in rabbit against Omps of S. 
Typhimurium. 
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Fig. 2. 1. Purified Omp28 protein. Lane M: Protein molecular weight marker (cat no. 105978), 
Lane 1: Purified rOmp28 protein, Lane 2: Whole cell protein of IPTG induced pQE30-Omp28 
transformed M-15 cells, Lane 3: Whole cell protein of untransformed M-15 cells. 2.2. Western 
blot analysis of Omp28 protein. M: Prestained protein molecular weight marker (SMO441),  
Lane 1: Purified protein.
Fig. 3. Sequence Alignment for Omp28 gene from Salmonella Typhi and Typhimurium. 
Nucleotide sequences showed 99% homology between S. Typhi and Typhimurium in NCBI blast.
In earlier reports Omp28 was also reported to be an immunogenic protein. NEVES-
FERREIRA et al. (2004) first characterized Omp28 protein in S. Typhi, and on the basis of 
its sero-reactivity reported it as an immunogenic protein. SAXENA et al. (2014) cloned, 
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expressed the protein in an E. coli host system and tested its immune-potential in a mouse 
model and observed that the mice produced a strong humoral response. On challenging 
it with a virulent strain of S. Typhi, the mortality was also significantly reduced. This 
study further confirms the immune-potential of Omp28 in the genus Salmonella. Upon 
comparison of Omp28 sequences between S. Typhi and Typhimurium, 99% of homology 
was observed (Fig. 3). Therefore, on this basis, the presumption may be made that the 
structures of both proteins may be very similar, and there is a strong possibility that 
Omp28 from S. Typhimurium is an immunogenic protein. 
In conclusion, the findings of this study, along with earlier reports, indicate that 
Omp28 is an antigenic protein. So, it is suggested that further animal protection studies 
should be carried out using the Omp28 protein of S. Typhimurium, because this protein 
may offer an alternative to existing vaccines for controlling salmonellosis, and could avoid 
the immense expense of treatment. Thus it may be used as a candidate for development of 
a recombinant subunit vaccine against non typhoidal salmonellosis in the future. 
_______
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SAŽETAK 
Salmonella Typhimurium glavni je gastrointestinalni patogen koji je globalna prijetnja ljudskome zdravlju. 
Javnozdravstveni problemi povezani s ovim organizmom povećali su se do te mjere da je postao glavno pitanje 
na koje se traže brojni odgovori. Bakterija postaje otporna na najčešće dostupne antibiotike, a ograničavajuća 
uporaba cjepiva povezana je s kratkotrajnim imunitetom. Zbog toga postoji hitna potreba za razvoj učinkovitog 
cjepiva. Vanjske bjelančevine membrane (engl. Outer membrane proteins, Omps) salmonele dokazale su svoju 
sposobnost kandidata za razvoj cjepiva koje bi se koristilo u prevenciji salmoneloze. S tim je ciljem u ovom 
radu, pod uvjetima IPTG indukcijskog sustava, provedeno umnažanje i kloniranje te provjerena izražajnost gena 
za Omp28 iz Salmonelle Typhimurium. Tako dobivena rekombinantna bjelančevina pročišćena je i testirana s 
obzirom na antigenu sposobnost. Antigena sposobnost pročišćene bjelančevine potvrđena je uporabom Western 
blot metode s antiserumom protiv Omps-a iz S. Typhimurium dobivenim od zeca. Genom Omp28 umnožen je 
kao 330bp produkt. Bjelančevina je imala približno 28 kDa i Western blot analizom pokazala je izraženost jakog 
signala. Ovim je istraživanjem zaključeno da Omp28 može poslužiti kao učinkoviti kandidat za razvoj r-DNA 
cjepiva protiv salmoneloze.
Ključne riječi: kloniranje; izražajnost; Omp28; Salmonella Typhimurium; cjepivo; Western blot________________________________________________________________________________________
